Journal of Drug Targeting is a well-established international journal dedicated to the advancement of drug delivery systems and targeted therapies. The journal focuses on innovative research and technological developments in directing therapeutic agents to specific sites within the body. Its scope encompasses the design, development, and evaluation of novel drug carriers and targeting strategies.
Key topics covered include nanoparticles, liposomes, antibodies, polymers, and other targeting moieties used to enhance drug efficacy and reduce side effects. The journal also explores the application of these technologies in various disease areas, including cancer, infectious diseases, and neurological disorders. Journal of Drug Targeting is indexed in databases such as Scopus, Web of Science, and PubMed, ensuring high visibility and accessibility for researchers worldwide. The journal's target audience comprises pharmaceutical scientists, chemists, biologists, and clinicians involved in drug delivery research and development.
This journal serves as a vital resource for the dissemination of cutting-edge research and the promotion of collaboration among scientists in the field. By publishing high-impact articles, it aims to accelerate the translation of innovative drug targeting strategies into clinical applications, ultimately improving patient outcomes. Consider submitting your original work to contribute to the ongoing advancements in this rapidly evolving area.